Decoy Therapeutics【DCOY】銘柄情報

Decoy Therapeutics Inc (DCOY) 銘柄情報

リアルタイムのディスカッションと取引のアイデア: 当社の強力なプラットフォームで自信を持って取引できます。

プレミアム

通貨

5.80

( -17.38% )

買値

5.80

売値

6.00

出来高

46,494

平均取引量 (3 か月)

US$ 231,879

財務取引量

US$ 295,898

5.94 日の範囲 7.23

0.53191 52 週間の範囲 13.51

時価総額

3.085M

企業価値

-3.932M

前日終値

7.02

始値

6.75

時刻

5.87

最終取引時間

VWAP

6.3642

歳入

純利益

-13.03M

発行済株式数

531,968

浮動株比率 (%)

99.41%

機関投資家保有比率 (%)

1.23%

配当利回り

PER

-0.13

株価売上高倍率 (PSR)

1 株当たり利益 (EPS)

-57.12

ベータ

0.59

Decoy Therapeutics Inc. operates as a pre-clinical stage biotechnology company. It focuses on advancing the peptide conjugate therapeutics through its Immediate Peptide/PPMO/P-PROTAC Alpha-helical Conjugate Technology (IMP3ACT) platform that leverages peptide coiled-coils chemistry and physics to de... Decoy Therapeutics Inc. operates as a pre-clinical stage biotechnology company. It focuses on advancing the peptide conjugate therapeutics through its Immediate Peptide/PPMO/P-PROTAC Alpha-helical Conjugate Technology (IMP3ACT) platform that leverages peptide coiled-coils chemistry and physics to design a-helical peptides through computational and ML tools. The company’s IMP3ACT platform leverages machine learning and artificial intelligence tools alongside synthesis techniques to engineer, enhance, and manufacture peptide conjugates targeting various unmet medical needs. It focuses on building a portfolio of peptide conjugate therapeutics focusing on infectious diseases and oncology. The company was formerly known as Salarius Pharmaceuticals, Inc. and change its name to Decoy Therapeutics Inc. in January 2026. Decoy Therapeutics Inc. is based in Houston, Texas. 詳細を表示

セクター

Healthcare

業界

Biotechnology & Life Sciences

ウェブサイト

decoytx.com

本社

Houston, United States

設立

Decoy Therapeutics Inc is listed in the Healthcare sector of the ナスダック市場 with ticker DCOY. The last closing price for Decoy Therapeutics was US$7.02. Over the last year, Decoy Therapeutics shares have traded in a share price range of US$ 0.53191 to US$ 13.51.

Decoy Therapeutics currently has 531,968 shares in issue. The market capitalisation of Decoy Therapeutics is US$3.09 million. Decoy Therapeutics has a price to earnings ratio (PE ratio) of -0.13.

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	-0.79	-11.9878603945	6.59	8.33	5.3	75432	7.46146029	CS
4	0.04	0.694444444444	5.76	13.51	5.29	749217	9.46595842	CS
12	-0.43	-6.90208667737	6.23	13.51	4.3201	246132	9.34798536	CS
26	5.0254	648.773560547	0.7746	13.51	0.53191	1129055	2.07178457	CS
52	5.0254	648.773560547	0.7746	13.51	0.53191	1129055	2.07178457	CS
156	5.0254	648.773560547	0.7746	13.51	0.53191	1129055	2.07178457	CS
260	5.0254	648.773560547	0.7746	13.51	0.53191	1129055	2.07178457	CS